Anticancer Drug Utilization and Prescription Practices at a Saudi Cancer Center: A Retrospective Study (2014–2022)

We conducted a retrospective cohort study of 510 adult patients with histologically confirmed malignant neoplasms that were managed with anti-cancer therapy at King Khaled Hospital, Najran, from 2014 to 2022. Data extraction included demographic characteristics, treatment regimens, and supportive medications, analyzed using IBM SPSS Statistics (version 21). Prescription quality was assessed against WHO EML criteria and Saudi Food and Drug Authority (SFDA) standards.

本研究针对2014年至2022年间，在奈兰市哈立德国王医院接受抗癌治疗的510例经组织学确诊的恶性肿瘤成年患者开展了一项回顾性队列研究。研究的数据提取内容涵盖人口统计学特征、治疗方案以及辅助用药，并采用IBM SPSS统计软件（版本21）进行数据分析。处方质量依据世界卫生组织基本药物标准清单（WHO EML）标准与沙特食品药品监督管理局（SFDA）规范开展评估。